Journal of Data Science

COVID-19 is a disease caused by the severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) that was reported to spread in people in December 2019. Understanding epidemiological

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronvirus, which was declared as a global pandemic by the World Health Organization on March 11, 2020. In this work, we conduct a cross-sectional study to investigate how the infection fatality rate (IFR) of COVID-19 may be associated with possible geographical or demographical features of the infected population. We employ a multiple index model in combination with sliced inverse regression to facilitate the relationship between the IFR and possible risk factors. To select associated features for the infection fatality rate, we utilize an adaptive Lasso penalized sliced inverse regression method, which achieves variable selection and sufficient dimension reduction simultaneously with unimportant features removed automatically. We apply the proposed method to conduct a cross-sectional study for the COVID-19 data obtained from two time points of the outbreak.

For large observational studies lacking a control group (unlike randomized controlled trials, RCT), propensity scores (PS) are often the method of choice to account for pre-treatment confounding in baseline characteristics, and thereby avoid substantial bias in treatment estimation. A vast majority of PS techniques focus on average treatment effect estimation, without any clear consensus on how to account for confounders, especially in a multiple treatment setting. Furthermore, for time-to event outcomes, the analytical framework is further complicated in presence of high censoring rates (sometimes, due to non-susceptibility of study units to a disease), imbalance between treatment groups, and clustered nature of the data (where, survival outcomes appear in groups). Motivated by a right-censored kidney transplantation dataset derived from the United Network of Organ Sharing (UNOS), we investigate and compare two recent promising PS procedures, (a) the generalized boosted model (GBM), and (b) the covariate-balancing propensity score (CBPS), in an attempt to decouple the causal effects of treatments (here, study subgroups, such as hepatitis C virus (HCV) positive/negative donors, and positive/negative recipients) on time to death of kidney recipients due to kidney failure, post transplantation. For estimation, we employ a 2-step procedure which addresses various complexities observed in the UNOS database within a unified paradigm. First, to adjust for the large number of confounders on the multiple sub-groups, we fit multinomial PS models via procedures (a) and (b). In the next stage, the estimated PS is incorporated into the likelihood of a semi-parametric cure rate Cox proportional hazard frailty model via inverse probability of treatment weighting, adjusted for multi-center clustering and excess censoring, Our data analysis reveals a more informative and superior performance of the full model in terms of treatment effect estimation, over sub-models that relaxes the various features of the event time dataset.

The COVID-19 (COrona VIrus Disease 2019) pandemic has had profound global consequences on health, economic, social, behavioral, and almost every major aspect of human life. Therefore, it is of great importance to model COVID-19 and other pandemics in terms of the broader social contexts in which they take place. We present the architecture of an artificial intelligence enhanced COVID-19 analysis (in short AICov), which provides an integrative deep learning framework for COVID-19 forecasting with population covariates, some of which may serve as putative risk factors. We have integrated multiple different strategies into AICov, including the ability to use deep learning strategies based on Long Short-Term Memory (LSTM) and event modeling. To demonstrate our approach, we have introduced a framework that integrates population covariates from multiple sources. Thus, AICov not only includes data on COVID-19 cases and deaths but, more importantly, the population’s socioeconomic, health, and behavioral risk factors at their specific locations. The compiled data are fed into AICov, and thus we obtain improved prediction by the integration of the data to our model as compared to one that only uses case and death data. As we use deep learning our models adapt over time while learning the model from past data.